Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102312605 | 10231260 | 5 | F | 201503 | 20160902 | 20140611 | 20160907 | EXP | US-GLAXOSMITHKLINE-A1075786A | GLAXOSMITHKLINE | 24.04 | YR | F | Y | 0.00000 | 20160907 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102312605 | 10231260 | 1 | PS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 21 NG/KG/MIN (CONCENTRATION 30,000 NG/ML, PUMP RATE 72 ML/DAY, VIAL STRENGTH 1.5 MG | U | S276 | 20444 | 21 | DF | POWDER FOR INFUSION | |||||
| 102312605 | 10231260 | 2 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 21 NG/KG/MIN | U | T794 | 20444 | POWDER FOR INFUSION | ||||||||
| 102312605 | 10231260 | 3 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 21 NG/KG/MIN | U | U383 | 20444 | 21 | DF | POWDER FOR INFUSION | ||||||
| 102312605 | 10231260 | 4 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 21 NG/KG/MIN, CO | U | Z880 | 20444 | 21 | DF | POWDER FOR INFUSION | |||||
| 102312605 | 10231260 | 5 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 22 NG/KG/MIN, CO | U | Z880 | 20444 | POWDER FOR INFUSION | ||||||||
| 102312605 | 10231260 | 6 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | U | C764454 | 0 | SOLUTION FOR INJECTION | |||||||||
| 102312605 | 10231260 | 7 | C | COUMADIN | WARFARIN SODIUM | 1 | U | 0 | |||||||||||
| 102312605 | 10231260 | 8 | C | ADCIRCA | TADALAFIL | 1 | U | 0 | |||||||||||
| 102312605 | 10231260 | 9 | C | AMOXICILLIN. | AMOXICILLIN | 1 | 500 MG, TID | U | 0 | 500 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102312605 | 10231260 | 1 | Pulmonary arterial hypertension |
| 102312605 | 10231260 | 6 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102312605 | 10231260 | HO |
| 102312605 | 10231260 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102312605 | 10231260 | Cardiac flutter | |
| 102312605 | 10231260 | Central venous catheterisation | |
| 102312605 | 10231260 | Device leakage | |
| 102312605 | 10231260 | Oropharyngeal pain | |
| 102312605 | 10231260 | Tooth infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102312605 | 10231260 | 1 | 20060905 | 0 | ||
| 102312605 | 10231260 | 9 | 20150311 | 0 |